Sol-gel Technologies Share Price (NASDAQ: SLGL)

$22.79

▲

0.89

(4.06%)

Last updated on August 30, 2025 at 1:29 am IST

$₹

Check the interactive Sol-gel Technologies Stock chart to analyse performance

Sol-gel Technologies stock performance

as on August 30, 2025 at 1:29 am IST

Today's Low:$22.24
Today's High:$22.79
$22.79
2.41%
Downside
Day's Volatility :2.41%
Upside
0.0%
52 Weeks Low:$4.01
52 Weeks High:$26.89
$22.79
82.42%
Downside
52 Weeks Volatility :85.1%
Upside
15.25%

Sol-gel Technologies Stock Returns

Period	Sol-gel Technologies Ltd	Sector (Health Care)	Index (Russel 2000)
3 Months	207.18%	3.6%	0.0%
6 Months	247.23%	-7.7%	0.0%
1 Year	227.59%	-12.6%	0.0%
3 Years	-63.06%	9.5%	-4.7%

Sol-gel Technologies Ltd Key Stats

Check Sol-gel Technologies key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$21.9
Open	$22.24
Today's High	$22.79
Today's Low	$22.24
Market Capitalization	$63.5M
Today's Volume	$12.9K
52 Week High	$26.89
52 Week Low	$4.006
Revenue TTM	$23.9M
EBITDA	$-4.6M
Earnings Per Share (EPS)	$-1.22
Profit Margin	-14.25%
Quarterly Earnings Growth YOY	4.88%
Return On Equity TTM	-10.21%

Stock Returns calculator for Sol-gel Technologies Stock including INR - Dollar returns

The Sol-gel Technologies stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Sol-gel Technologies investment value today

Current value as on today

₹3,31,321

Returns

₹2,31,321

(+231.32%)

Returns from Sol-gel Technologies Stock

₹2,26,037 (+226.04%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Sol-gel Technologies Stock

47%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Sol-gel Technologies Stock from India on INDmoney has increased by 47% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Sol-gel Technologies Ltd

Name
Holdings %
Name
Holdings %
Phoenix Financial Ltd
8.87%
Migdal Insurance & Financial Holdings Ltd
4.41%
Harel Insurance Invests & Fin Srvcs Ltd
3.30%
Yelin Lapidot Holdings Management Ltd
0.64%
Morgan Stanley - Brokerage Accounts
0.33%
MENORA MIVTACHIM HOLDINGS LIMITED
0.27%

Analyst Recommendation on Sol-gel Technologies Stock

Rating

Trend

Buy

87%Buy

12%Hold

0%Sell

Based on 8 Wall street analysts offering stock ratings for Sol-gel Technologies(by analysts ranked 0 to 5 stars)

Sol-gel Technologies Share Price Target

What analysts predicted

Downside of 82.45%

Target:

$4.00

Current:

$22.79

Sol-gel Technologies share price target is $4.00, a slight Downside of 82.45% compared to current price of $22.79 as per analysts' prediction.

Sol-gel Technologies Stock Insights

Price Movement
In the last 1 month, SLGL stock has moved up by 78.2%
Increasing Revenue
Revenue is up for the last 3 quarters, 278.0K → 17.26M (in $), with an average increase of 83.5% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -8.80M → 11.61M (in $), with an average increase of 175.9% per quarter
SLGL vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 175.5%

Sol-gel Technologies Ltd Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$22.9M	↑ 17655.04%
Net Income	$-24.6M	↓ 23.58%
Net Profit Margin	-107.44%	↑ 24856.13%

	FY20	Y/Y Change
Revenue	$8.8M	↓ 61.71%
Net Income	$-27.4M	↑ 11.35%
Net Profit Margin	-312.4%	↓ 204.96%

	FY21	Y/Y Change
Revenue	$31.3M	↑ 256.54%
Net Income	$4.4M	↓ 115.9%
Net Profit Margin	13.94%	↑ 326.34%

	FY22	Y/Y Change
Revenue	$3.9M	↓ 87.58%
Net Income	$-13.6M	↓ 412.12%
Net Profit Margin	-350.3%	↓ 364.24%

	FY23	Y/Y Change
Revenue	$1.6M	↓ 59.98%
Net Income	$-27.2M	↑ 100.25%
Net Profit Margin	-1.8K%	↓ 1402.47%

	FY24	Y/Y Change
Revenue	$11.5M	↑ 642.47%
Net Income	$-10.6M	↓ 61.16%
Net Profit Margin	-91.7%	↑ 1661.07%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$466.0K	↑ 4.25%
Net Income	$-6.3M	↑ 31.18%
Net Profit Margin	-1.4K%	↓ 279.49%

	Q2 FY24	Q/Q Change
Revenue	$5.4M	↑ 1065.88%
Net Income	$2.0M	↓ 131.15%
Net Profit Margin	36.37%	↑ 1397.74%

	Q3 FY24	Q/Q Change
Revenue	$5.4M	↓ 1.33%
Net Income	$-366.0K	↓ 118.52%
Net Profit Margin	-6.83%	↓ 43.2%

	Q4 FY24	Q/Q Change
Revenue	$278.0K	↓ 94.81%
Net Income	$-5.8M	↑ 1497.27%
Net Profit Margin	-2.1K%	↓ 2096.05%

	Q1 FY25	Q/Q Change
Revenue	$1.0M	↑ 270.86%
Net Income	$-8.8M	↑ 50.67%
Net Profit Margin	-854.32%	↑ 1248.56%

	Q2 FY25	Q/Q Change
Revenue	$17.3M	↑ 1574.2%
Net Income	$11.6M	↓ 231.81%
Net Profit Margin	67.26%	↑ 921.58%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$-17.7M	↓ 36.92%

	FY20	Y/Y Change
Profit	$8.8M	↓ 149.63%

	FY21	Y/Y Change
Profit	$10.9M	↑ 24.17%

	FY22	Y/Y Change
Profit	$-8.8M	↓ 180.79%

	FY23	Y/Y Change
Profit	$1.2M	↓ 113.77%

	FY24	Y/Y Change
Profit	$11.3M	↑ 832.76%

Q1 FY24

Q2 FY24

Q3 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$-4.9M	↑ 31.02%

	Q2 FY24	Q/Q Change
Profit	$3.0M	↓ 161.39%

	Q3 FY24	Q/Q Change
Profit	$5.4M	↑ 79.0%

	Q1 FY25	Q/Q Change
Profit	$1.0M	-

	Q2 FY25	Q/Q Change
Profit	$17.3M	↑ 1574.2%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$-22.5M	↓ 4.12%
Investing Cash Flow	$16.0M	↓ 129.28%
Financing Cash Flow	$10.6M	↓ 86.53%

	FY20	Y/Y Change
Operating Cash Flow	$-25.2M	↑ 12.18%
Investing Cash Flow	$-2.7M	↓ 116.81%
Financing Cash Flow	$26.5M	↑ 149.29%

	FY21	Y/Y Change
Operating Cash Flow	$-7.7M	↓ 69.53%
Investing Cash Flow	$19.9M	↓ 837.64%
Financing Cash Flow	$837.0K	↓ 96.84%

	FY22	Y/Y Change
Operating Cash Flow	$-9.5M	↑ 23.31%
Investing Cash Flow	$1.7M	↓ 91.45%
Financing Cash Flow	$15.0K	↓ 98.21%

	FY23	Y/Y Change
Operating Cash Flow	$-17.7M	↑ 86.95%
Investing Cash Flow	$-9.7M	↓ 673.4%
Financing Cash Flow	$21.8M	↑ 145300.0%

	FY24	Y/Y Change
Operating Cash Flow	$-13.9M	↓ 21.66%
Investing Cash Flow	$26.7M	↓ 373.99%
Financing Cash Flow	$0.0	↓ 100.0%

Q2 FY19

Q4 FY19

Q2 FY20

Q4 FY20

Q4 FY22

	Q2 FY19	Q/Q Change
Operating Cash Flow	$-4.5M	↑ 59.1%
Investing Cash Flow	$78.9M	↑ 39.97%
Financing Cash Flow	$-78.8M	↑ 55.1%

	Q4 FY19	Q/Q Change
Operating Cash Flow	$-9.7M	↑ 113.06%
Investing Cash Flow	$-5.9M	↓ 107.49%
Financing Cash Flow	$10.6M	↓ 113.46%

	Q2 FY20	Q/Q Change
Operating Cash Flow	$-9.6M	↓ 0.93%
Investing Cash Flow	$-20.1M	↑ 239.33%
Financing Cash Flow	$26.5M	↑ 149.29%

	Q4 FY20	Q/Q Change
Operating Cash Flow	$-3.2M	↓ 66.1%
Investing Cash Flow	$42.0M	↓ 309.36%
Financing Cash Flow	$-26.5M	↓ 200.0%

	Q4 FY22	Q/Q Change
Operating Cash Flow	$1.9M	↓ 112.07%
Investing Cash Flow	$39.9M	↑ 129.96%
Financing Cash Flow	$-25.6M	-

Sol-gel Technologies Technicals Summary

Sell

Neutral

Buy

Sol-gel Technologies is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Sol-gel Technologies Ltd Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Sol-gel Technologies Ltd	71.08%	247.23%	227.59%	-63.06%	-70.39%
Regeneron Pharmaceuticals, Inc.	6.48%	-15.2%	-50.31%	-3.3%	-2.01%
Beone Medicines Ltd	1.77%	24.81%	62.78%	79.11%	29.69%
Vertex Pharmaceuticals Incorporated	-14.45%	-19.13%	-17.84%	34.68%	41.87%
Alnylam Pharmaceuticals, Inc.	13.79%	83.28%	75.87%	111.28%	242.25%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Sol-gel Technologies Ltd	18.42	NA	NA	0.0	-0.1	-0.07	NA	11.45
Regeneron Pharmaceuticals, Inc.	14.6	14.6	1.2	39.42	0.15	0.07	0.0	287.55
Beone Medicines Ltd	NA	NA	NA	2.73	-0.05	-0.01	NA	34.32
Vertex Pharmaceuticals Incorporated	27.86	27.86	0.58	18.06	0.23	0.13	NA	67.02
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	3.92	-2.58	-0.03	NA	1.91

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Sol-gel Technologies Ltd	Buy	$63.5M	-70.39%	18.42	-14.25%
Regeneron Pharmaceuticals, Inc.	Buy	$61.4B	-2.01%	14.6	31.37%
Beone Medicines Ltd	NA	$36.5B	29.69%	NA	-3.89%
Vertex Pharmaceuticals Incorporated	Buy	$100.5B	41.87%	27.86	31.86%
Alnylam Pharmaceuticals, Inc.	Buy	$59.5B	242.25%	NA	-12.96%

About Sol-gel Technologies Ltd

Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel, China, Switzerland, Canada, and internationally. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea. It also develops SGT-610 that is in Phase 3 clinical trials for the treatment of Gorlin Syndrome; and SGT-210, which has completed Phase I clinical trial, to treat rare hyperkeratinization disorders, such as Darier, PC, PPK, Olmsted, etc. It has collaboration with Padagis Israel Pharmaceuticals Ltd; and license agreements with Galderma Holding SA and Searchlight Pharma Inc. Sol-Gel Technologies Ltd. was incorporated in 1997 and is headquartered in Ness Ziona, Israel.

Organization	Sol-gel Technologies
Employees	34
CEO	Mr. Moshe Arkin
Industry	Health Technology

Key Management of Sol-gel Technologies Ltd

Name	Title
Mr. Moshe Arkin	CEO & Executive Chairman
Mr. Eyal Ben-Or	Chief Financial Officer
Dr. Itzik Yosef	Chief Operating Officer
Mr. Michael Glezin	Chief Business Officer

Important FAQs about investing in SLGL Stock from India :

What is Sol-gel Technologies share price today?

Sol-gel Technologies share price today is $22.79 as on August 30, 2025 at 1:29 am IST at the close of the market. Sol-gel Technologies share today touched a day high of $22.79 and a low of $22.24.

What is the 52 week high and 52 week low for Sol-gel Technologies share?

Sol-gel Technologies share touched a 52 week high of $26.89 and a 52 week low of $4.01. Sol-gel Technologies stock price today i.e. August 30, 2025 at 1:29 am IST is closed at $22.79, lower by 15.25% versus the 52 week high.

How to invest in Sol-gel Technologies Stock (SLGL) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Sol-gel Technologies on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Sol-gel Technologies Shares that will get you 0.0658 shares as per Sol-gel Technologies share price of $22.79 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Sol-gel Technologies Stock (SLGL) from India?

Indian investors can start investing in Sol-gel Technologies (SLGL) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Sol-gel Technologies stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Sol-gel Technologies share’s latest price of $22.79 as on August 30, 2025 at 1:29 am IST, you will get 0.4388 shares of Sol-gel Technologies. Learn more about fractional shares .

What are the returns that Sol-gel Technologies has given to Indian investors in the last 5 years?

Sol-gel Technologies stock has given -70.39% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?